The influence of familial and hereditary factors on the prognosis of breast cancer

Annals of Oncology

Volumn 10, Issue 10, 1999, Pages 1163-1170

  Chappuis, P O ^a,b   Rosenblatt, J ^a   Foulkes, W D ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

BRCA1; BRCA2; Breast cancer; Family history; Survival

Indexed keywords

BREAST CANCER; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; FAMILY HISTORY; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

BRCA2 PROTEIN; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LINKAGE (GENETICS); NEOPLASM PROTEINS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 0032716188     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008301314812     Document Type: Review

References (58)

1. Pharoah PD, Day NE, Duffy S et al. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997; 71: 800-9.
2. Welcsh PL, Schubert EL, King MC. Inherited breast cancer: An emerging picture. Clin Genet 1998; 54: 447-58.
3. Sankila R, Aaltonen LA, Jarvinen HJ et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996; 110: 682-7.
4. Watson P, Lin KM, Rodriguez-Bigas MA et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998; 83: 259-66.
5. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505-10.
6. Marcus JN, Page DL, Watson P et al. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 1997; 80: 543-56.
7. Crook T, Crossland S, Crompton MR et al. p53 mutations in BRCA1-associated familial breast cancer. Lancet 1997; 350: 638-9.
8. Eisinger F, Nogues C, Birnbaum D et al. Low frequency of lymph-node metastasis in BRCA1-associated breast cancer. Lancet 1998; 351: 1633-4 (Letter).
9. Johannsson OT, Idvall I, Anderson C et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 1997; 33: 362-71.
10. Lynch BJ, Holden JA, Buys SS et al. Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 1998; 29: 1140-4.
11. Tirkkonen M, Johannsson O, Agnarsson BA et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997; 57: 1222-7.
12. Bertwistle D, Ashworth A. Functions of the BRCA1 and BRCA2 genes. Curr Opin Genet Dev 1998; 8: 14-20.
13. Blackwood MA, Weber BL. BRCA1 and BRCA2: From molecular genetics to clinical medicine. J Clin Oncol 1998; 16: 1969-77.
14. Greenberg ER, Vessey MP, McPherson K et al. Body size and survival in premenopausal breast cancer. Br J Cancer 1985; 51: 691-7.
15. Chabner E, Nixon A, Gelman R et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1998; 16: 2045-51.
16. Mohammed SN, Smith P, Hodgson SV et al. Family history and survival in premenopausal breast cancer. Br J Cancer 1998; 77: 2252-6.
17. Ruder AM, Moodie PF, Nelson NA et al. Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 1988; 158: 963-8.
18. Slattery ML, Berry TD, Kerber RA. Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 1993; 4: 543-8.
19. Malone KE, Daling JR, Weiss NS et al. Family history and survival of young women with invasive breast carcinoma. Cancer 1996; 78: 1417-25.
20. Langlands AO, Kerr GR, Bloomer SM. Familial breast cancer. Clin Oncol 1976; 2: 41-5.
21. Albano WA, Recabaren JA, Lynch HT et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982; 50: 360-3.
22. Hermann RE, Esselstyn CB, Crue G et al. Results of conservative operations for breast cancer. Arch Surg 1985; 120: 746-51.
23. Anderson DE, Badzioch MD. Survival in familial breast cancer patients. Cancer 1986; 58: 360-5.
24. Wobbes T, van de Wiel MP, van der Sluis RF et al. The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol 1987; 13: 119-21.
25. Lees AW, Jenkins HJ, May CL et al. Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 1989; 13: 143-51.
26. Fukutomi T, Kobayashi Y, Nanasawa T et al. A clinicopathological analysis of breast cancer in patients with a family history. Surg Today 1993; 23: 849-54.
27. Israeli D, Tartter PI, Brower ST et al. The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 1994; 179: 29-32.
28. Peterson M, Fowble B, Solin LJ et al. Family history status as a prognostic factor for breast cancer patients treated with conservative surgery and irradiation. Breast J 1995; 1: 202-9.
29. Chen LM, Mundt AJ, Powers C et al. Significance of family history in breast cancer treated with breast conservation therapy. Breast J 1996; 2: 238-45.
30. Schouten LJ, Hupperets PS, Jager JJ et al. Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 1997; 43: 217-23.
31. Haas JA, Schultz DJ, Peterson ME et al. An analysis of age and family history on outcome after breast-conservation treatment: The University of Pennsylvania experience. Cancer J Sci Am 1998; 4: 308-15.
32. Porter DE, Cohen BB, Wallace MR et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81: 1512-5.
33. Marcus JN, Watson P, Page DL et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996; 77: 697-709.
34. Sigurdsson H, Agnarsson BA, Jonasson JG et al. Worse survival among breast cancer patients in families carrying the BRCA2 susceptibility gene. Breast Cancer Res Treat 1996; 37 (Suppl): 33 (Abstr).
35. Foulkes WD, Wong N, Brunet JS et al. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 1997; 3: 2465-9.
36. Agnarsson BA, Jonasson JG, Björnsdottir IB et al. Inherited BRCA2 mutation associated with high-grade breast cancer. Breast Cancer Res Treat 1998; 47: 121-7.
37. Ansquer Y, Gautier C, Fourquet A et al. Survival in early-onset BRCA1 breast-cancer patients. Lancet 1998; 352: 541 (Letter).
38. Gaffney DK, Brohet RM, Lewis CM et al. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol 1998; 47: 129-36.
39. Garcia-Patino E, Gomendio B, Provencio M et al. Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations. J Clin Oncol 1998; 16: 115-20.
40. Johannsson OT, Ranstam J, Borg A et al. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden. J Clin Oncol 1998; 16: 397-404.
41. Robson M, Gilewski T, Haas B et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16: 1642-9.
42. Verhoog LC, Brekelmans CT, Seynaeve C et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351: 316-21.
43. Wagner TM, Moslinger RA, Muhr Det al. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: Specific BRCA1 mutations and pathological characteristics. Int J Cancer 1998; 77: 354-60.
44. Lee JS, Wacholder S, Struewing JP et al. Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91: 259-63.
45. Kerber RA, Slattery ML. Comparison of self-reported and data-base-linked family history of cancer data in a case-control study. Am J Epidemiol 1997; 146: 244-8.
46. Anton-Culver H, Kurosaki T, Taylor TH et al. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. Genet Epidemiol 1996; 13: 193-205.
47. Khoury MJ, Flanders WD. Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 1995; 6: 511-9.
48. Foulkes WD, Brunet JS, Sieh W et al. Familial risks of squamous cell carcinoma of the head and neck: Retrospective case-control study. BMJ 1996; 313: 716-21.
49. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 1998; 82: 1310-8.
50. Edwards MJ, Gamel JW, Vaughan WP et al. Infiltrating ductal carcinoma of the breast: The survival impact of race. J Clin Oncol 1998; 16: 2693-9.
51. Narod S, Ford D, Devilee P et al. Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 1995; 57: 957-8 (Letter).
52. Narod SA, Goldgar D, Cannon-Albright L et al. Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 1995; 64: 394-8.
53. Vogel F, Motulsky AG. Formal genetics of humans: Modes of inheritance. In Vogel F, Motulsky AG (eds): Human Genetics: Problems and Approaches, 3rd ed. Berlin: Springer-Verlag 1997; 129-62.
54. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
55. Armes JE, Egan AJ, Southey MC et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study. Cancer 1998; 83: 2335-45.
56. Narod SA. Host susceptibility to cancer progression. Am J Hum Genet 1998; 63: 1-5.
57. Schrag D, Kuntz KM, Garber JE et al. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336: 1465-71.
58. Hartmann LC, Schaid DJ, Woods JE et al. Efficacity of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Eng J Med 1999; 340: 77-84.